Phase III, Multicenter, Ramdomised, Open-Label, Study to Evaluate the Safety and Efficacy of Combination Therapy With XELOX Vs. Oxaliplatin and 5-FU CI as First Line Treatment in Advanced or Metastatic Colorectal Cancer.

Trial Profile

Phase III, Multicenter, Ramdomised, Open-Label, Study to Evaluate the Safety and Efficacy of Combination Therapy With XELOX Vs. Oxaliplatin and 5-FU CI as First Line Treatment in Advanced or Metastatic Colorectal Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jul 2015

At a glance

  • Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Oxaliplatin (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top